Main clinicopathological features of HER2-negative tumors according to HER2-low expression and tumor phenotype in primary and recurrent breast cancer cohorts are summarized in Supplementary Tables 1 and 2, respectively. The gene discussed is ERBB2; the disease is breast cancer.